ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » General Practice

Top General Practice Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ABNER LUTHER MD

General Practice

28,086

$1.44M

380
342 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

38%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

MICHAEL REEVES MD

General Practice

46,350

$2.75M

904
765 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $51

JOHN WAGNER M.D., C.M.D.

General Practice

85,781

$4.68M

1447
1273 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

36%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

MALCOLM BROWN MD

General Practice

38,182

$2.14M

965
825 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

BRUCE RUSSELL MD

General Practice

28,561

$1.38M

473
316 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

54%
patients receiving schedule three controlled substances

Avg: 27%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $51

OLUDAYO DAWODU MD

General Practice

13,124

$866K

502
356 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $51

J HOLMES MD

General Practice

23,636

$1.3M

730
436 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

44%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

ASHLEY MCINTYRE MD

General Practice

12,067

$618K

329
208 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

ROBERT SCHUSTER MD

General Practice

21,019

$1.23M

1109
484 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $51

JOHN KERR M.D.

General Practice

21,631

$1.06M

532
379 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

JOHN SIMMONS M.D

General Practice

23,837

$1.18M

637
458 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

RALPH NEAL MD

General Practice

15,071

$693K

652
473 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

JESS YOUNGBLOOD M.D.

General Practice

27,922

$1.61M

766
298 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

41%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $51

BILL YATES MD

General Practice

4,798

$172K

191
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

40%
patients receiving schedule three controlled substances

Avg: 27%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $51

COREY GILLILAND D.O.

General Practice

1,708

$79.3K

135
102 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

JOHN SIMMONS MD

General Practice

5,819

$242K

413
209 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

STEPHEN CHROMIAK MD

General Practice

1,426

$38.6K

204
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 22%

$27
Average prescription price

Avg: $51

PETER LITCHFIELD MD

General Practice

1,646

$84.2K

404
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

31%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

ROBERT BARTEL MD

General Practice

9,565

$602K

331
138 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

46%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $51

MIQUEL SANTIAGO

General Practice

14,956

$502K

551
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 27%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$34
Average prescription price

Avg: $51

MATTHEW PARKER M.D.

General Practice

527

$39.7K

69
23 are 65+

29%
patients receiving schedule two controlled substances

Avg: 7%

41%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $51

CHARLES BUCKMASTER M.D.

General Practice

2,273

$137K

128
43 are 65+

39%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $51

JANIE TESCHNER M.D.

General Practice

2,610

$122K

122
16 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

49%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $51

ROBERT THEAKSTON M.D.

General Practice

3,992

$152K

294
177 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

31%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $51

DAVID FERNANDEZ M.D.

General Practice

855

$17.8K

456
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 22%

$21
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank